Results 11 to 20 of about 85,740 (261)
Molecular aspects of MERS-CoV [PDF]
Frontiers of Medicine, 2017 This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Ahmed, Shamsah H. +3 more
core +4 more sources
Prospects for a MERS-CoV spike vaccine [PDF]
Expert Review of Vaccines, 2018 Introduction: Six years have passed since Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV), a newly emerging infectious virus, was first reported in 2012.
Yusen Zhou, Shibo Jiang, Lanying Du
doaj +3 more sources
Development of Small-Molecule MERS-CoV Inhibitors [PDF]
Viruses, 2018 Middle East respiratory syndrome coronavirus (MERS-CoV) with potential to cause global pandemics remains a threat to the public health, security, and economy. In this review, we focus on advances in the research and development of small-molecule MERS-CoV
Ruiying Liang +10 more
doaj +3 more sources
MERS CoV infection - ecological investigations [PDF]
International Journal of Infectious Diseases, 2014 S.F. Fagbo +7 more
doaj +2 more sources
, 2019 About the Special Issue Editors Fang Li is an Associate Professor in the Department of Veterinary and Biomedical Sciences at the University of Minnesota. His main line of research examines the invasion mechanisms of viruses. Specifically, his group investigates the structures and functions of virus-surface proteins that mediate receptor recognition and
Du, Lanying, Li, Fang
+6 more sources
MERS-CoV: Bridging the Knowledge Gaps
Oman Medical Journal, 2014 Since its emergence in September 2012 and as of 30 April 2014, there have been 424 cases of the Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) reported to public health authorities worldwide (15 countries). This tally includes 95 healthcare workers (22%) and 131 deaths (mortality rate of 31%).1 To date, only two laboratory confirmed cases have
Abdullah Balkhair +4 more
openalex +4 more sources
Emerging Microbes and Infections, 2020 Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) causes a severe respiratory disease in humans. The MERS-CoV spike (S) glycoprotein mediates viral entry into target cells.
Hannah Kleine-Weber +8 more
doaj +1 more source
A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines. [PDF]
PLoS ONE, 2013 An emerging respiratory infectious disease with high mortality, Middle East respiratory syndrome (MERS), is caused by a novel coronavirus (MERS-CoV). It was first reported in 2012 in Saudi Arabia and has now spread to eight countries.
Lanying Du +10 more
doaj +1 more source